Coeptis Therapeutics Holdings, Inc. (COEP) Interest Expense USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
  • Coeptis Therapeutics Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $201 K, a 538% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $277 K, a 42.7% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $108 K, a 50.7% decline from 2022.
  • Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $218 K, a 16.7% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $277 K $201 K +$169 K +538% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $108 K $13.8 K -$28.5 K -67.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $136 K $19.8 K -$36.6 K -64.9% Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-03-25
Q2 2023 $173 K $42.6 K -$21.2 K -33.2% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-03-25
Q1 2023 $194 K $31.4 K -$24.4 K -43.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $218 K $42.3 K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $56.4 K Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-25
Q2 2022 $63.8 K Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-03-25
Q1 2022 $55.8 K Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.